Iron and infection: New developments and their implications

Journal of Trauma - Injury, Infection and Critical Care

Volumn 41, Issue 2, 1996, Pages 356-364

  Ward, C Gillon ^a,b   Bullen, J J ^b   Rogers, Henry J ^c  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; TRANSFERRIN;

BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIOSTASIS; HOST RESISTANCE; HUMAN; INFECTION PREVENTION; INFECTION RESISTANCE; IRON METABOLISM; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW; TRANSFERRIN BLOOD LEVEL; WOUND INFECTION;

EID: 0029764649     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-199608000-00030     Document Type: Review

References (83)

1. Bullen JJ, Ward CG, Rogers HJ: The critical role of iron in some clinical infections. Eur J Clin Microbiol Infect Dis 10:613, 1991
2. Cassel GH: New and emerging infections in the face of a funding crisis: ASM news. Am Soc Microbiol 60:251, 1994
3. Chin GJ, Marx J (eds): Resistance to antibiotics. Science 264:359, 1994
4. Robson MC: Introduction: The equilibrium between bacteria and the host. In Heggers JP, Robson MC (eds): Quantitative Bacteriology: Its Role in the Armamentarium of the Surgeon Boca Raton, Fla, CRC Press, 1991, pp 1-8
5. Bullen JJ, Spalding PB, Ward CG, et al: The role of Eh, pH and iron in the bactericidal power of human plasma. FEMS Microbiol Lett 94:47, 1992
6. Bullen JJ, Rogers HJ, Griffiths E: Role of iron in bacterial infection. Curr Top Microbiol Immunol 80:1, 1978
7. Chaberek S, Martell AE: Organic Sequestering Agents. New York, John Wiley & Sons, 1959, p 446
8. Griffiths E: Adaptation and multiplication of bacteria in host tissues. Philo Trans R Soc Lond E Biol Sci 303:85, 1983
9. Michelsen PA, Sparling PF: Ability of Neisseria gonorrhoea, Neisseria meningitidis and commensal Neisseria to obtain iron from transferrin and iron compounds. Infect Immun 33:555, 1981
10. Taylor PW: Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. Microbiol Rev 47:46, 1983
11. Ward CG, Hammond JS, Bullen JJ: Effect of iron compounds on antibacterial function of human polymorphs and plasma. Infect Immun 51:723, 1986
12. Bullen JJ: The significance of iron in infection. Rev Infect Dis 3:1127, 1981
13. Robins-Browne RM, Prpic JK: Effects of iron and desferrioxamine on infections with Yersinia enterocolitica. Infect Immun 47:774, 1985
14. Brock JH, Ng J: The effect of desferrioxamine on the growth of Staphylococcus aureus, Yersinia enterocolitica, and Streptococcus faecalis in human serum: Uptake of desferrioxamine-bound iron. FEMS Microbiol Lett 20:439, 1983
15. Jackson S, Morris BC: Enhancement of growth of Pasteurella pestis and other bacteria in serum by the addition of iron. Br J Exp Pathol 42:363, 1961
16. Bullen JJ, Ward CG, Wallis SN: Virulence and the role of iron in Pseudomonas aeruginosa infection. Infect Immun 10:443, 1974
17. Bullen JJ, Rogers HJ, Lewin JE: The bacteriostatic effect of serum on Pasteurella septica and its abolition by iron compounds. Immunology 20:391, 1971
18. Bullen JJ, Spalding PB, Ward CG, et al: Hemochromatosis, iron and septicemia caused by Vibrio vulnificus. Arch Intern Med 151:1606, 1991
19. Rogers HJ: Bacteriostatic effects of horse sera and serum fractions on Clostridium welchii Type A, and the abolition of bacteriostasis by iron salts. Immunology 12:285, 1967
20. Carolyne L, Rosner F, Kozinn PJ: Elevated serum iron, low unbound transferrin and candidiasis in acute leukaemia. Blood 34:441, 1969
21. Fletcher J: The effect of iron and transferrin on the killing of Escherichia coli in fresh serum. Immunology 20:493, 1971
22. Hegenauer J, Saltman P: Iron and susceptibility to infectious disease. Science 188:1038, 1975
23. Bullen JJ, Ward CG, Rogers HJ: Iron, infection, and the role of bicarbonate. FEMS Microbiol Lett 71:27, 1990
24. Griffiths E: Mechanism of action of specific antiserum on Pasteurella septica: selective inhibition of net macromolecular synthesis and its reversal by iron compounds. Eur J Biochem 23:69, 1971
25. Griffiths E: Metabolically controlled killing of Pasteurella septica by antibody and complement. Biochim Biophys Acta 362:598, 1974
26. Bagg A, Neilands JB: Ferric uptake regulation protein acts as a repressor, employing iron(II) as a cofactor to bind the operator of an iron transport operon in Escherichia coli. Biochemistry 26:5471, 1987
27. Postle K: Aerobic regulation of the Escherichia coli Ton B gene by changes in iron availability and the fur locus. J Bacteriol 172:2287, 1990
28. Skare JT, Postle K: Evidence for a Ton B dependent energy transduction complex in Escherichia coli. Mol Microbiol 5:2883, 1991
29. Gutteridge JMC: Bleomycin-iron in biological fluids: What does the assay measure? In Rice-Evans C, Halliwell B (eds): Free Radicals: Methodology and Concepts. London, Richelieu Press, 1988, pp 429-445
30. Eaton JW, Brandt P, Mahoney JR, et al: Haptoglobin: A natural bacteriostat. Science 215:691, 1982
31. Bullen JJ, Leigh L, Rogers HJ: The effect of iron compounds on the virulence of Escherichia coli for guinea pigs. Immunology 15:581, 1968
32. Lee JT, Ahrenholz DH, Nelson RD, et al: Mechanism of the adjuvant effect of hemoglobin in experimental peritonitis. V. The significance of the coordinated iron component. Surgery 86:41, 1979
33. Griffiths E, Cortes A, Gilbert N, et al: Haemoglobin-based blood substitute and sepsis. Lancet 345:159, 1995
34. Kluger MJ, Bullen JJ: Clinical and physiological aspects. In Bullen JJ, Griffiths E (eds): Iron and Infection: Molecular, Physiological and Clinical Aspects. Chichester, England, John Wiley and Sons, 1987, pp 243-282
35. Otto BR, Verweij-van Vught AMJJ, MacLaren DM: Blood substitutes and infection. Nature 358:23, 1992
36. Bornside CH, Bouis PJ, Cohn I: Hemoglobin and Escherichia coli, a lethal intraperitoneal combination. J Bacteriol 95:1567, 1968
37. Krizek TJ, Davis JH: The role of the red cell in subcutaneous infection. J Trauma 5:85, 1965
38. Lee LA, Gerber AR, Lonsway DR, et al: Yersinia enterocolitica 0:3 infections in infants and children associated with the household preparation of chitterlings. N Engl J Med 322:984, 1990
39. Mofenson HC, Caraccio TR, Sharieff N: Iron sepsis: Yersinia enterocolitica septicemia possibly caused by an iron overdose. N Engl J Med 316:1092, 1987
40. Melby K, Slordahl S, Gutterberg TJ, et al: Septicaemia due to Yersinia enterocolitica after oral over-doses of iron. Br Med J 285:467, 1982
41. Wright AC, Simpson LM, Oliver JD: Role of iron in the pathogenesis of Vibrio vulnificus. Infect Immun 34:503, 1981
42. Janda JM, Powers C, Bryant RG, et al: Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp. Clin Microbiol Rev 1:245, 1988
43. Forsberg CM, Bullen JJ: The effect of passage and iron on the virulence of Pseudomonas aeruginosa. J Clin Pathol 25:65, 1972
44. Robson MC, Duke WF, Krizek TJ: Rapid bacterial screening in the treatment of civilian wounds. J Surg Res 14:426, 1973
45. Muller-Eberhard U: Hemopexin. N Engl J Med 283:1090, 1970
46. Rudolf AS, Cliff RO: Dry storage of liposome-encapsulated hemoglobin: A blood substitute. Cryobiology 27:585, 1990
47. Hunt TK, Twomey P, Zederfeldt B, et al: Respiratory gas tensions and pH in healing wounds. Am J Surg 114:302, 1967
48. Pasquale MD, Cipolle MD, Cerra FB: Maximization of oxygen delivery: A plea for objective patient care and research. J Trauma 34:775, 1993
49. Rogers HJ, Bullen JJ, Cushnie GH: Iron compounds and resistance to infection: Further experiments with Clostridium welchii Type A in-vivo and in-vitro. Immunology 12:285, 1970
50. Fildes P: Tetanus IX: The oxidation-reduction potential of the subcutaneous tissue fluid of the guinea-pig - Its effect on infection. Br J Exp Pathol 10:197, 1929
51. Bullen JJ, Dobson A, Wilson AB: Bacteriostatic effects of specific antiserum on Clostridium welchii Type A: The role of Eh and pH of the medium. J Gen Microbiol 35:175, 1964
52. Bullen JJ: Role of toxins in host-parasite relationships. In Ajl SJ, Kadis S, Montie TC (eds): Microbial Toxins, vol I. San Diego, Academic Press, 1970, pp 233-276
53. Stoner HB, Bullen JJ, Cushnie GH, et al: Fatal intraperitoneal infection with Clostridium welchii Type A in passively immunised guinea-pigs: The effect on vascular permeability. Br J Exp Pathol 48:309, 1967
54. Bullen JJ, Cushnie GH, Stoner HB: Oxygen uptake by Clostridium welchii Type A: Its possible role in experimental infections in passively immunised animals. Br J Exp Pathol 47:488, 1966
55. Hewitt LF: Oxidation-Reduction Potentials in Bacteriology and Biochemistry. Edinburgh, E. & S. Livingstone, 1950, pp 95-129
56. Bullen JJ, Wilson AB, Cushnie GH, et al: The abolition of the protective effect of Pasteurella septica antiserum by iron compounds. Immunology 14:889, 1968
57. Bullen JJ, Cushnie GH, Rogers HJ: The abolition of the protective effect of Clostridium welchii Type A antiserum by ferric iron. Immunology 12:303, 1967
58. Bullen JJ, Wallis SN, Griffiths E: The effect of antipolymorphonuclear leucocyte serum on Pseudomonas aeruginosa infection in rabbits. Immunology 30:603, 1967
59. Brubaker RR: Factors promoting acute and chronic disease caused by Yersinia. Clin Microbiol Rev 4:309, 1991
60. Jackson S, Burrows TW: The virulence enhancing effect of iron on non-pigmented mutants of virulent strains of Pasteurella pestis. Br J Exp Pathol 37:527, 1956
61. Esterly NB, Brammer SR, Crounse RG: The relationship of transferrin and iron to serum inhibition of Candida albicans. J Invest Dermatol 49:437, 1967
62. Fletcher J, Goldstein E: The effect of parenteral iron preparation on experimental pyelonephritis. Br J Exp Pathol 51:280, 1970
63. Pruett TL, Rotstein OR, Fiegel VD, et al: Mechanism of adjuvant effect of hemoglobin in experimental peritonitis VIII: A leukotoxin is produced by Escherichia coli metabolism in hemoglobin. Surgery 96:375, 1984
64. Kim Y-M, Yamazaki I, Piette LH: The effect of hemoglobin, hematin, and iron on neutrophil inactivation in superoxide generating systems. Arch Biochem Biophys 309:308, 1994
65. Wooldridge KG, Williams PH: Iron uptake mechanisms of pathogenic bacteria. FEMS Microbiol Rev 12:325, 1993
66. Rogers HJ: Iron binding catechols and virulence in Escherichia coli. Infect Immun 7:445, 1973
67. Snow GA: Mycobactins: Iron-chelating growth factors from mycobacteria. Bacteriol Rev 34:99, 1970
68. Rogers HJ, Woods VE, Synge C: Antibacterial effects of the scandium and indium complexes of enterochclin on Escherichia coli. J Gen Microbiol 128:2389, 1982
69. Rogers HJ, Synge C, Woods VE: Antibacterial effect of scandium and idium complexes of enterochelin on Klebsiella pneumoniae. Antimicrob Agents Chemother 18:63, 1980
70. Rogers HJ, Plaha DS, Woods VE: Antibacterial effect of the scandium complex of enterochelin on Pseudomonas aeruginosa. FEMS Microbiol Lett 24:5, 1984
71. Plaha DS, Rogers HJ: Antibacterial effect of the scandium complex of enterochelin: Studies of the mechanism of action. Biochim Biophys Acta 760:246, 1983
72. Plaha DS, Rogers HJ, Williams GW: Studies of the antibacterial effect of the scandium complex of enterochelin. J Antibiot (Tokyo) 37:588, 1984
73. Rogers HJ: Bacterial iron transport as a target for antibacterial agents. In Winkelmann G, van der Helm D, Neilands JB (eds): Iron Transport in Microbes, Plants, and Animals. Weinheim, Germany, VCH, 1987, pp 223-233
74. Rogers HJ: Synthesis of enterochelin. J. Chem Soc [Perkin I] p 3073, 1995
75. Sunagawa M, Sasaki A, Yamaga H, et al: Synthesis and antibacterial activity of novel carbapenems with a catechol or hydroxypridone moiety. J Antibiot (Tokyo) 47:1354, 1994
76. Hantke K: Dihydroxybenzoylserine: A siderophore for Escherichia coli. FEMS Microbiol Lett 67:5, 1990
77. Benz G, Schroder T, Kurz J, et al: Constitution of the defferiform of albomycins δ1, δ2 and ∈. Angew Chem Int Ed Engl 21:527, 1982
78. Braun V, Gunther K, Hantke K, et al: Intracellular activation of albomycin in Escherichia coli and Salmonella typhimurium. J Bacteriol 156:308, 1983
79. Rusnak F, Sakaitani M, Drueckhammer D, et al: Biosynthesis of the Escherichia coli siderophore enterobactin: Sequence of the Ent F gene, expression and purification of Ent F, and analysis of covalent phosphopantetheine. Biochemistry 30:2916, 1991
80. Perry RD, Brubaker RR: Accumulation of iron by Yersiniae. J Bacteriol 137:1290, 1979
81. Pidcock KA, Wooten JA, Daley BA, et al: Iron acquisition by Haemophilus influence. Infect Immun 56:721, 1988
82. Levere RD, Swerdlow F, Garavoy MR: Measurement of human plasma hemoglobin by difference spectrophotometry. J Lab Clin Med 77:168, 1971
83. Wilson APR: Donor serum for peritonitis? Lancet 343:807, 1994